Canakinumab for treating periodic fever syndromes: TRAPS, HIDS/MKD and FMF (ages 2 years and older)

Document first published:: 6 March 2020
Page updated:: 6 March 2020
Topic:: Specialised commissioning
Publication type:: Policy or strategy, Report

NHS England will commission canakinumab for treating periodic fever syndromes: TRAPS HIDS/MKD and FMF in accordance with the criteria outlined in this document.

Document

Canakinumab for treating periodic fever syndromes TRAPS HIDS/MKD and FMF (ages 2 years and older)

Canakinumab for treating periodic fever syndromes TRAPS HIDS/MKD and FMF (ages 2 years and older)

PDF
226 KB
20 pages

Document

Clinical Panel Report

Clinical Panel Report

PDF
201 KB
2 pages

Document

Consultation Report

Consultation Report

PDF
48 KB
3 pages

Document

CPAG Summary Report

CPAG Summary Report

PDF
94 KB
10 pages

Document

Evidence Review

Evidence Review

PDF
616 KB
80 pages

Document

Stakeholder engagement report

Stakeholder engagement report

PDF
45 KB
3 pages